Acute Disease - 176 Studies Found
Completed |
: Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study : Acute Leukemia : 2012-03-15 : Behavioral: Health counseling and exercise The intervention is initiated during chemotherapy treatment ( |
Recruiting |
: Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute Leukemia : Acute Leukemia : 2011-12-19 : Drug: Busulfan Iv busulfan 1.6mg/kg q12h D1- D4 Othe |
Completed |
: Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL) : Acute Leukemia : 2011-05-10 : Other: Exercise based multimodal intervention The intervention is initiated early, during treatment (con |
Completed |
: Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children : Acute Leukemia : 2011-06-21 : Drug: Clofarabine VP 16 ciclophospahamide Clofarabine intravenously 2-hour infusion,dose 40 mg/m2, follo |
Completed |
: Pilot Study of Hematopoietic Stem Cell Transplantation From Two Matched Sibling Donors in Treating Patients With Poor Prognosis Acute Leukemia and Advanced Lymphoproliferative Malignancies : Relapsed and Refractory Acute Leukemia : 2011-06-28 : Biological: Double matched sibling transplantation Patient |
Completed |
: Impact of CT on Diagnosis of Acute Appendicitis : Acute Appendicitis : 2011-06-17 : Other: CT scanning CT image of the abdomen included the area between the 3rd. lumber vertebra and the to |
Active, not recruiting |
: POETIC Plerixafor as a Chemosensitizing Agent for Relapsed Acute Leukemia and MDS in Pediatric Patients :
|
Completed |
: Demonstration of Near Zero Antibiotic Prescribing for Acute Bronchitis :
: 2010-11-10 : Behavioral: Demonstration of near zero antibiotic prescribing for patients with acute bronchitis A contr |
Completed |
: Study of IRNEA (Irinotecan, Etoposide, Cytarabine) for Refractory or Relapsed Acute Leukemia in Children and Adolescents : Acute Leukemia : 2010-11-08 : Drug: Irinotecan Chemotherapy: irinotecan, etoposide, and |
Terminated |
: A Study for Patients With Acute Leukemia : Acute Leukaemia : 2010-10-01 : Drug: LY2523355 Administered intravenously for at least 2 cycles. Cycle length is 21 days. Participants |